# reload+after+2024-01-23 10:44:59.181749
address1§1 Commonwealth Lane, No. 08-22
city§Singapore
zip§149544
country§Singapore
phone§65 6250 7738
website§https://w2.cytomed.sg
industry§Biotechnology
sector§Healthcare
longBusinessSummary§CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers in Malaysia and Singapore. Its lead product candidate is CTM-N2D, which is in Phase I clinical trials comprising expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore.
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Chee Kong  Choo', 'age': 65, 'title': 'Executive Chairman', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 5454, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Wee Kiat  Tan Ph.D.', 'age': 36, 'title': 'COO & Director', 'yearBorn': 1987, 'fiscalYear': 2022, 'totalPay': 67442, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jieming  Zeng', 'age': 50, 'title': 'Chief Scientific & Medical Officer and Director', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 78481, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tien Wee  Luk', 'age': 37, 'title': 'Chief Clinical Officer & Director', 'yearBorn': 1986, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Yvonne  Goh', 'age': 33, 'title': 'Chief Financial Officer', 'yearBorn': 1990, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Yoong Ying  Tan', 'age': 34, 'title': 'Chief Corporate Officer', 'yearBorn': 1989, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
priceToSalesTrailing12Months§89.04362
currency§USD
dateShortInterest§1702598400
forwardEps§-0.2
exchange§NCM
quoteType§EQUITY
shortName§CytoMed Therapeutics Limited
longName§CytoMed Therapeutics Limited
firstTradeDateEpochUtc§1681479000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§5fbb5a07-c64c-3457-b39c-0446de45b69d
gmtOffSetMilliseconds§-18000000
targetHighPrice§5.0
targetLowPrice§5.0
targetMeanPrice§5.0
targetMedianPrice§5.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§36.423
grossMargins§0.98067003
ebitdaMargins§0.0
trailingPegRatio§None
